The Fujifilm AMULET Innovality – a highly advanced mammography system representing evolving technology and a commitment to enhanced patient care.
• The original dual-mode DBT acquisition, optimised for screening and diagnostic mammography
• Proprietary HCP technology and ISR iterative processing for proven dose reduction
• S-View software enables switching from tomosynthesis acquisition to 2D imaging with no additional exposures for real workflow and dose benefits
• Patented Fit Sweet Paddle; a flexible, adaptive compression paddle designed for maximum patient comfort
• Stereotactic and tomo-guided biopsy targeting, with vertical and lateral needle access for faster and more accurate interventional mammography
• Support for advanced clinical application with Contrast Enhanced Mammography
New Dynamic Visualization™ II image processing offers intelligent auto-recognition of breast tissue, implant and structural characteristics, delivering greater levels of stability throughout the entire exposure region. This enhances diagnostic visibility across a wide range of breast morphology. New Fujifilm technology allows breast density detection and measurement directly from the AMULET Innovality providing a truly seamless workflow. New The Fujifilm Academy of Breast Imaging (FABI) will deliver a series
of clinician-led lectures offering delegates the opportunity to explore the latest technology, trends and innovations in digital mammography. FROM TECHNOLOGY TO INNOVATION, FROM INNOVATION TO CARE
Hologic is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. We are committed to leading in breast health through constant innovation, and are dedicated to evolving screening and interventional technology to continue serving the needs of our customers and their patients. We continue to drive innovation in breast health to provide high-quality mammograms for physicians, supplying them with the most accurate information. Our 3D Mammography™ exam is proven to offer better, earlier, breast cancer detection compared to conventional mammography alone, enabling physicians to provide patients with earlier diagnosis and reduced chance of call backs.
For patients, we are delivering minimally invasive biopsy solutions that enable an improved patient experience without clinical compromise. Our Brevera™ breast biopsy system with CorLumina™ imaging technology is the first system to offer clinicians both breast biopsy as well as real-time verification of specimens – streamlining workflow, expediting the procedure and creating a gentler patient experience. None of this would be possible without the talent and passion of our employees. Together, our expertise and dedication to developing and sharing more robust, science based certainty drives our increasingly global presence and a promising pipeline that responds to the unmet health and wellness needs of women, families and communities.
Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to achieve better outcomes at lower costs by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalising healthcare. With an understanding and focus on the unique healthcare needs of women, we offer healthcare providers solutions to prevent, detect, and treat the most threatening diseases affecting their female patients throughout all stages of their lives. For further information visit www.siemens.co.uk/sympmammo